Gene · 1284
Papers2,425
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,425
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiple golgins are required to support extracellular matrix secretion, modification, and assembly. | J Cell Biol | 2025 | 40824304 | PubTator, text mining | PubMed |
| Local genetic sex differences in quantitative traits. | Nat Commun | 2025 | 40770183 | PubTator, text mining | PubMed |
| Human Omental Mesothelial Cells Exhibit a Corneal Endothelial-Like Cell Phenotype for Tissue Engineering of a Corneal Endothelium Biomimetic. | Invest Ophthalmol Vis Sci | 2025 | 40762540 | PubTator, text mining | PubMed |
| Collagen IV in Gould syndrome and Alport syndrome. | Nat Rev Nephrol | 2025 | 40745060 | PubTator, text mining | PubMed |
| Comparative transcriptomic and genomic analysis of tumor cells in the marginal and center regions of tumor nests in human hepatocellular carcinoma. | Front Cell Dev Biol | 2025 | 40741331 | PubTator, text mining | PubMed |
| Biomechanical control of vascular morphogenesis by the surrounding stiffness. | Nat Commun | 2025 | 40721407 | PubTator, text mining | PubMed |
| Rapid genetic testing in the PICU: uncovering COL4A2-related GOULD syndrome in super-refractory status epilepticus. | BMJ Case Rep | 2025 | 40716787 | PubTator, text mining | PubMed |
| Hypoxia-mediated HES4 promotes the proliferation and motility of hepatocellular carcinoma cell by enhancing COL4A2 transcription. | Discov Oncol | 2025 | 40715599 | PubTator, text mining | PubMed |
| Identification of genetic variants associated with Fabry nephropathy progression using whole-exome sequencing. | Mol Genet Metab | 2025 | 40663814 | PubTator, text mining | PubMed |
| Novel autosomal dominant syndromic hearing loss caused by COL4A2 -related basement membrane dysfunction of cochlear capillaries and microcirculation disturbance. | Chin Med J (Engl) | 2025 | 40629513 | PubTator, text mining | PubMed |
| COL4A1 and COL4A2-related disorders: Clinical features, diagnostic guidelines, and management. | Genet Med | 2025 | 40616396 | PubTator, text mining | PubMed |
| Pediatric pulmonary hemorrhage observed in non-vascular and vascular Ehlers-Danlos syndrome. | Orphanet J Rare Dis | 2025 | 40598578 | PubTator, text mining | PubMed |
| miR-29a-3p participates in the pathogenesis of spontaneous abortion by inhibiting trophoblast function targeting COL4A2/COL5A1. | Biochem Pharmacol | 2025 | 40562119 | PubTator, text mining | PubMed |
| Integrative transcriptomics and single-cell transcriptomics analyses reveal potential biomarkers and mechanisms of action in papillary thyroid carcinoma. | Front Genet | 2025 | 40520228 | PubTator, text mining | PubMed |
| Comprehensive genome-wide analysis of retinal vessel caliber reveals microvascular-blood pressure pathways: advancing predictive, preventive, and personalized medicine. | EPMA J | 2025 | 40438498 | PubTator, text mining | PubMed |
| Transcriptomics of Anterior Shoulder Instability: Differences in Gene Expression in the Blood of Patients With and Without Significant Glenoid Bone Loss. | Orthop J Sports Med | 2025 | 40386647 | PubTator, text mining | PubMed |
| Blood biochemical landscape and new insights into clinical decision-making for polycystic ovary syndrome in Chinese women: a prospective cohort study. | Front Endocrinol (Lausanne) | 2025 | 40375948 | PubTator, text mining | PubMed |
| Prognostic significance and multivariate modeling of COL4A family genes and HMGA2 in glioma. | Front Pharmacol | 2025 | 40351420 | PubTator, text mining | PubMed |
| Integrated bulk RNA and single-cell analysis with experimental validation reveal oxidative stress-related diagnostic biomarkers for osteoporosis. | PLoS One | 2025 | 40299834 | PubTator, text mining | PubMed |
| Investigation of the Pathogenesis of Liver Fibrosis Associated with Type 2 Diabetes Mellitus via Bioinformatic Analysis. | Biomedicines | 2025 | 40299397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1284/papers?page=6